-
Mandatory COVID-19 Tests Lifted for Vaccinated Travelers to Britain
drugs.com
February 11, 2022
Vaccinated travelers will no longer have to take COVID-19 tests when they enter Britain, officials announced Friday.
-
Plant “biofactories” produce proteins for potential COVID-19 vaccine
EuropeanPharmaceuticalReview
February 10, 2022
COVID-19 is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). SARS-CoV-2 replicates by infecting human cells via the interaction of the receptor-binding domain (RBD) on the viral Spike (S) protein...
-
Some Canadian Provinces Lift COVID Restrictions Amid Ongoing Protests
drugs.com
February 10, 2022
Four Canadian provinces said this week that they'll lift their COVID-19 restrictions as the wave of cases caused by the Omicron variant has crested nationwide.
-
Seqirus Announces New Facility Supporting R&D of Leading-Edge Influenza Vaccine Technology
AmericanPharmaceuticalReview
February 09, 2022
Seqirus, a business of CSL Limited, announced an investment in a new Research and Development (R&D) facility located in Waltham, Mass. The new facility will support the company's growing R&D portfolio...
-
Moderna to supply 10.8 million Covid-19 vaccine doses to Colombia
Pharmaceutical-Technology
February 09, 2022
Initially, Moderna plans to supply one million doses of the vaccine in the first quarter of this year.
-
Sustainability vs single-use-tech: how COVID-19 has made biopharma more sustainable
CPhIonline
February 09, 2022
COVID-19 saw biopharma turn to single-use technology in a big way. But greater use of disposable manufacturing systems does not necessarily mean drug and vaccine production has become less environmentally sustainable.
-
Study finds COVID-19 less severe in fully vaccinated
WorldPharmaNews
February 07, 2022
The clinical and imaging characteristics of COVID-19 breakthrough infections in fully vaccinated patients tend to be milder than those of partially vaccinated or unvaccinated patients...
-
Parental vaccination against coronavirus offers substantial protection to children as well
WorldPharmaNews
February 07, 2022
The Clalit Research Institute, in collaboration with researchers from Harvard University and Tel-Aviv University, analyzed one of the world’s largest integrated health record databases to examine the indirect protection...
-
Gerresheimer Expands Injection Vials Production
contractpharma
February 07, 2022
Investment increases production in Wertheim by 150 million vials and creates 70 new jobs.
-
Moderna starts trial for Omicron-specific booster shot
ExpressPharma
January 29, 2022
The company said while a third shot of its original coronavirus vaccine increased neutralising antibodies against the variant at the lower dose, their levels declined six months after the booster dose was administered...